 antithrombin iii supplement reduc requir platelet loss hemodialysi patient fulmin hepat failur previou studi antithrombin iii level low fulmin hepat failur heparin kinet abnorm control heparin difficult hemodialysi patient risk studi trial antithrombin iii supplement heparin activ occurr bleed platelet count activ hemodialysi patient fulmin hepat failur treat group patient unit antithrombin iii hemodialysi antithrombin iii supplement antithrombin iii level hemodialysi prelevel u/ml s.e hr u/ml control prelevel u/ml hr u/ml total heparin usag antithrombin iii supplement median rang control group median rang blood heparin level antifactor Xa activ initi bolu antithrombin iii-suppl subject u/ml u/ml control group signific reduct platelet count control patient hr antithrombin iii patient hr releas platelet-specif protein beta-thromboglobulin patient group minor bleed vascular access site first hemodialysi